Location History:
- Toshima-ku, JP (2015)
- Tokyo, JP (2016)
Company Filing History:
Years Active: 2015-2016
Title: Innovations of Shin-ichi Shirokawa
Introduction
Shin-ichi Shirokawa is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in developing treatments for various mental and physical health disorders. With a total of 2 patents, his work has the potential to impact many lives.
Latest Patents
Shirokawa's latest patents include innovative azole derivatives aimed at treating or preventing a range of diseases. These include mood disorders, anxiety disorders, schizophrenia, Alzheimer's disease, Parkinson's disease, Huntington's chorea, eating disorders, hypertension, gastrointestinal diseases, drug addiction, epilepsy, cerebral infarction, cerebral ischemia, cerebral edema, head injuries, inflammation, immune-related diseases, and alopecia. His inventions provide agents that act as antagonists against the arginine-vasopressin (AVP) V1b receptor, showcasing his commitment to advancing medical science.
Career Highlights
Shin-ichi Shirokawa is currently associated with Taisho Pharmaceutical Co., Ltd., where he continues to innovate and develop new pharmaceutical solutions. His work is characterized by a focus on pharmacokinetics, ensuring that his compounds not only treat diseases effectively but also do so with favorable absorption and distribution in the body.
Collaborations
Shirokawa collaborates with notable colleagues, including Mitsukane Yoshinaga and Takeshi Kuwada. These partnerships enhance the research and development process, allowing for a more comprehensive approach to tackling complex health issues.
Conclusion
Shin-ichi Shirokawa's contributions to the pharmaceutical industry through his innovative patents demonstrate his dedication to improving health outcomes. His work continues to pave the way for new treatments that address critical health challenges.